{
    "startDate": "2018-04-01",
    "endDate": "2018-09-30",
    "year": "2019",
    "quarter": "Q2",
    "symbol": "UROV",
    "data": {
        "bs": [
            {
                "label": "Cash",
                "concept": "Cash",
                "unit": "usd",
                "value": 1659000
            },
            {
                "label": "Prepaid expenses and other current assets",
                "concept": "PrepaidExpenseAndOtherAssetsCurrent",
                "unit": "usd",
                "value": 11757000
            },
            {
                "label": "Deferred initial public offering costs",
                "concept": "DeferredOfferingCosts",
                "unit": "usd",
                "value": 2201000
            },
            {
                "label": "Current assets:",
                "concept": "AssetsCurrent",
                "unit": "usd",
                "value": 15617000
            },
            {
                "label": "Property and equipment, net",
                "concept": "PropertyPlantAndEquipmentNet",
                "unit": "usd",
                "value": 587000
            },
            {
                "label": "Other assets",
                "concept": "AssetsNoncurrentOtherThanNoncurrentInvestmentsAndPropertyPlantAndEquipment",
                "unit": "usd",
                "value": 84000
            },
            {
                "label": "Assets",
                "concept": "Assets",
                "unit": "usd",
                "value": 16288000
            },
            {
                "label": "Accounts payable",
                "concept": "AccountsPayableCurrent",
                "unit": "usd",
                "value": 5084000
            },
            {
                "label": "Accrued expenses",
                "concept": "AccruedLiabilitiesCurrent",
                "unit": "usd",
                "value": 9875000
            },
            {
                "label": "Due to Roivant Sciences Ltd.",
                "concept": "DueToRelatedPartiesCurrent",
                "unit": "usd",
                "value": 8056000
            },
            {
                "label": "Liabilities and Shareholder's (Deficit) Equity",
                "concept": "Liabilities",
                "unit": "usd",
                "value": 23015000
            },
            {
                "label": "Commitments and contingencies (Note 8)",
                "concept": "CommitmentsAndContingencies",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Common shares, par value $0.000037453 per share, 267,001,308 shares authorized, 20,025,098 issued and outstanding at September 30, 2018 and March 31, 2018, respectively",
                "concept": "CommonStockValue",
                "unit": "usd",
                "value": 1000
            },
            {
                "label": "Common shares subscribed",
                "concept": "CommonStockShareSubscribedButUnissuedSubscriptionsReceivable",
                "unit": "usd",
                "value": 1000
            },
            {
                "label": "Shareholder receivable",
                "concept": "StockholdersEquityNoteSubscriptionsReceivable",
                "unit": "usd",
                "value": 1310000
            },
            {
                "label": "Accumulated other comprehensive income",
                "concept": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
                "unit": "usd",
                "value": 104000
            },
            {
                "label": "Additional paid-in capital",
                "concept": "AdditionalPaidInCapitalCommonStock",
                "unit": "usd",
                "value": 114601000
            },
            {
                "label": "Accumulated deficit",
                "concept": "RetainedEarningsAccumulatedDeficit",
                "unit": "usd",
                "value": -120122000
            },
            {
                "label": "Shareholder's (deficit) equity",
                "concept": "StockholdersEquity",
                "unit": "usd",
                "value": -6727000
            },
            {
                "label": "Liabilities and Shareholder's (Deficit) Equity",
                "concept": "LiabilitiesAndStockholdersEquity",
                "unit": "usd",
                "value": 16288000
            }
        ],
        "cf": [
            {
                "label": "Net loss",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -55937000
            },
            {
                "label": "Depreciation and amortization",
                "concept": "DepreciationAndAmortization",
                "unit": "usd",
                "value": 85000
            },
            {
                "label": "Share-based compensation expense",
                "concept": "ShareBasedCompensation",
                "unit": "usd",
                "value": 1795000
            },
            {
                "label": "Unrealized foreign currency translation adjustment",
                "concept": "ForeignCurrencyTransactionGainLossUnrealized",
                "unit": "usd",
                "value": -97000
            },
            {
                "label": "Prepaid expenses and other current assets",
                "concept": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
                "unit": "usd",
                "value": 6561000
            },
            {
                "label": "Due to Roivant Sciences Ltd.",
                "concept": "IncreaseDecreaseInDueToRelatedPartiesCurrent",
                "unit": "usd",
                "value": 6574000
            },
            {
                "label": "Accounts payable",
                "concept": "IncreaseDecreaseInAccountsPayable",
                "unit": "usd",
                "value": 3801000
            },
            {
                "label": "Accrued expenses",
                "concept": "IncreaseDecreaseInAccruedLiabilities",
                "unit": "usd",
                "value": 5802000
            },
            {
                "label": "Cash flows from operating activities:",
                "concept": "NetCashProvidedByUsedInOperatingActivities",
                "unit": "usd",
                "value": -44344000
            },
            {
                "label": "Purchases of property and equipment",
                "concept": "PaymentsToAcquirePropertyPlantAndEquipment",
                "unit": "usd",
                "value": 162000
            },
            {
                "label": "Cash flows from investing activities:",
                "concept": "NetCashProvidedByUsedInInvestingActivities",
                "unit": "usd",
                "value": -162000
            },
            {
                "label": "Proceeds from capital contributions from Roivant Sciences Ltd.",
                "concept": "ProceedsFromContributedCapital",
                "unit": "usd",
                "value": 40244000
            },
            {
                "label": "Initial public offering costs paid",
                "concept": "PaymentsOfStockIssuanceCosts",
                "unit": "usd",
                "value": 1273000
            },
            {
                "label": "Cash flows from financing activities:",
                "concept": "NetCashProvidedByUsedInFinancingActivities",
                "unit": "usd",
                "value": 38971000
            },
            {
                "label": "Net change in cash",
                "concept": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
                "unit": "usd",
                "value": -5535000
            },
            {
                "label": "Unpaid initial public offering costs included in accounts payable and accrued expenses.",
                "concept": "urov:UnpaidInitialPublicOfferingCostsIncludedInAccountsPayableAndAccruedExpenses",
                "unit": "usd",
                "value": 928000
            },
            {
                "label": "Income taxes",
                "concept": "IncomeTaxesPaidNet",
                "unit": "usd",
                "value": 155000
            }
        ],
        "ic": [
            {
                "label": "Research and development",
                "concept": "ResearchAndDevelopmentExpense",
                "unit": "usd",
                "value": 48009000
            },
            {
                "label": "General and administrative",
                "concept": "GeneralAndAdministrativeExpense",
                "unit": "usd",
                "value": 7788000
            },
            {
                "label": "Operating expenses:",
                "concept": "OperatingExpenses",
                "unit": "usd",
                "value": 55797000
            },
            {
                "label": "Other income (expense):",
                "concept": "NonoperatingIncomeExpense",
                "unit": "usd",
                "value": -80000
            },
            {
                "label": "Loss before provision for income taxes",
                "concept": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
                "unit": "usd",
                "value": -55877000
            },
            {
                "label": "Provision for income taxes",
                "concept": "IncomeTaxExpenseBenefit",
                "unit": "usd",
                "value": 60000
            },
            {
                "label": "Net loss",
                "concept": "NetIncomeLoss",
                "unit": "usd",
                "value": -55937000
            },
            {
                "label": "Net loss per common share\u2014basic and diluted",
                "concept": "EarningsPerShareBasicAndDiluted",
                "unit": "usd/shares",
                "value": -2.79
            },
            {
                "label": "Weighted average common shares outstanding\u2014basic and diluted",
                "concept": "WeightedAverageNumberOfShareOutstandingBasicAndDiluted",
                "unit": "shares",
                "value": 20025098
            },
            {
                "label": "Foreign currency translation adjustment",
                "concept": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent",
                "unit": "usd",
                "value": 97000
            },
            {
                "label": "Other comprehensive income (loss):",
                "concept": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
                "unit": "usd",
                "value": 97000
            },
            {
                "label": "Comprehensive loss",
                "concept": "ComprehensiveIncomeNetOfTax",
                "unit": "usd",
                "value": -55840000
            }
        ]
    }
}